Log in to save to my catalogue

A novel C19ORF12 mutation in two MPAN sisters treated with deferiprone

A novel C19ORF12 mutation in two MPAN sisters treated with deferiprone

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a9974bd6dd74919aadedd919f538770

A novel C19ORF12 mutation in two MPAN sisters treated with deferiprone

About this item

Full title

A novel C19ORF12 mutation in two MPAN sisters treated with deferiprone

Publisher

England: BioMed Central Ltd

Journal title

BMC neurology, 2023-03, Vol.23 (1), p.134-134, Article 134

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a rare and devastating disease caused by pathogenic mutations in C19orf12 gene. MPAN is characterized by pathological iron accumulation in the brain and fewer than 100 cases of MPAN have been described. Although the diagnosis of MPAN has achieved a great breakthrough with the app...

Alternative Titles

Full title

A novel C19ORF12 mutation in two MPAN sisters treated with deferiprone

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7a9974bd6dd74919aadedd919f538770

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a9974bd6dd74919aadedd919f538770

Other Identifiers

ISSN

1471-2377

E-ISSN

1471-2377

DOI

10.1186/s12883-023-03172-z

How to access this item